Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials-Reference-Cited by-同舟云学术

Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials

Published:2020-05 Issue:1 Volume:107 Page:136-142
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Alayed Yasir,Davidson Melanie,Liu Stanley,Chu William,Tseng Eric,Cheung Patrick,Vesprini Danny,Cheung Hans,Morton Gerard,Musunuru H.B.,Ravi Anath,Korol Renee,Deabreu Andrea,Ho Ling,Commisso Kristina,Bhounr Zeeba,D’Alimonte Laura,Mittmann Nicole,Dragomir Alice,Zhang Liang,Loblaw Andrew

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference22 articles.

1. Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013;Amin;Appl Health Econ Health Policy,2014

2. Stereotactic body radiotherapy for prostate cancer;Henderson;Clin Oncol,2015

3. Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer;Kishan;JAMA Netw Open,2019

4. Dose escalation for prostate stereotactic ablative radiotherapy (SABR): late outcomes from two prospective clinical trials;Alayed;Radiother Oncol,2018

5. Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials;King;Radiother Oncol,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials;Clinical and Translational Radiation Oncology;2024-11

2. Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial;Radiation Oncology;2024-05-03

3. Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancer;Clinical and Translational Radiation Oncology;2024-03

4. Towards optimal heterogeneous prostate radiotherapy dose prescriptions based on patient‐specific or population‐based biological features;Medical Physics;2024-01-15

5. CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer;Clinical and Translational Radiation Oncology;2024-01